1. Home
  2. TMDX vs FRSH Comparison

TMDX vs FRSH Comparison

Compare TMDX & FRSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TMDX
  • FRSH
  • Stock Information
  • Founded
  • TMDX 1998
  • FRSH 2010
  • Country
  • TMDX United States
  • FRSH United States
  • Employees
  • TMDX N/A
  • FRSH N/A
  • Industry
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • FRSH EDP Services
  • Sector
  • TMDX Health Care
  • FRSH Technology
  • Exchange
  • TMDX Nasdaq
  • FRSH Nasdaq
  • Market Cap
  • TMDX 3.9B
  • FRSH 3.7B
  • IPO Year
  • TMDX 2019
  • FRSH 2021
  • Fundamental
  • Price
  • TMDX $114.30
  • FRSH $12.22
  • Analyst Decision
  • TMDX Buy
  • FRSH Buy
  • Analyst Count
  • TMDX 11
  • FRSH 16
  • Target Price
  • TMDX $130.73
  • FRSH $19.44
  • AVG Volume (30 Days)
  • TMDX 1.0M
  • FRSH 4.2M
  • Earning Date
  • TMDX 10-29-2025
  • FRSH 11-05-2025
  • Dividend Yield
  • TMDX N/A
  • FRSH N/A
  • EPS Growth
  • TMDX 170.70
  • FRSH N/A
  • EPS
  • TMDX 2.54
  • FRSH N/A
  • Revenue
  • TMDX $566,354,000.00
  • FRSH $810,640,000.00
  • Revenue This Year
  • TMDX $38.84
  • FRSH $17.01
  • Revenue Next Year
  • TMDX $20.46
  • FRSH $13.02
  • P/E Ratio
  • TMDX $45.35
  • FRSH N/A
  • Revenue Growth
  • TMDX 41.20
  • FRSH 18.18
  • 52 Week Low
  • TMDX $55.00
  • FRSH $10.51
  • 52 Week High
  • TMDX $145.50
  • FRSH $19.77
  • Technical
  • Relative Strength Index (RSI)
  • TMDX 40.85
  • FRSH 63.22
  • Support Level
  • TMDX $115.21
  • FRSH $10.52
  • Resistance Level
  • TMDX $125.57
  • FRSH $12.26
  • Average True Range (ATR)
  • TMDX 7.65
  • FRSH 0.39
  • MACD
  • TMDX -1.72
  • FRSH 0.16
  • Stochastic Oscillator
  • TMDX 12.41
  • FRSH 95.11

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

About FRSH Freshworks Inc.

Freshworks Inc provides software as a service platform that enables small and medium-sized businesses to support customers through e-mail, phone, website, and social networks. It offers solutions that serve the needs of users in the CS and ITSM categories and has also expanded its offering with Sales and Marketing automation products. These product offerings enable organizations to acquire, engage, and serve their customers and employees. The group derives revenue from North America, Europe, the Middle East and Africa, Asia Pacific, and Other regions.

Share on Social Networks: